# Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation

> **NCT01705964** · PHASE4 · COMPLETED · sponsor: **University of Louisville** · enrollment: 49 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** IM epinephrine 1:1000
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01705964
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01705964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01705964, "Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01705964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*